Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease
- Ann. Oncol., Volume 28, Issue 9, 1 September 2017, Pages 2199-2205 | https://doi.org/10.1093/annonc/mdx316
